Phospho-MLKL (Ser358) Rekombinanter Antikörper
Phospho-MLKL (Ser358) Rekombinant Antikörper für WB, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
241469D2
Kat-Nr. : 82090-2-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
82090-2-PBS bindet in WB, Indirect ELISA Phospho-MLKL (Ser358) und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | Peptid |
| Vollständiger Name | mixed lineage kinase domain-like |
| Berechnetes Molekulargewicht | 54 kDa |
| Beobachtetes Molekulargewicht | 54 kDa |
| GenBank-Zugangsnummer | XM_005255834 |
| Gene symbol | MLKL |
| Gene ID (NCBI) | 197259 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein A purfication |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Mixed lineage kinase domain like pseudokinase (MLKL), belongs to the protein kinase superfamily. One common method for inducing necroptosis is by treating cells grown in culture with a mixture composed of TNF-α, a Smac-mimetic, that degrades cellular inhibitors of apoptosis (cIAPs) and the pancaspase inhibitor Z-VAD-FMK. This mixture is abbreviated as T/S/Z. It drives necrosome complex formation and RIPK3-dependent phosphorylation of Thr-357 and Ser-358 located within the C-terminal kinase-like domain of human MLKL. (PMID: 28878015)

